impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Letters to the Editor

 

Intravenous immunoglobulin in the treatment of sporadic inclusion body myositis: time for new evidence?

1, 2, 3, 4, 5, 6, 7

 

  1. Health Science Interdisciplinary Centre, Sant’Anna School of Advanced Studies, Pisa, and Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy. lorenzo.fontanelli@santannapisa.it
  2. Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  3. Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  4. Neurology Unit, Neuromotor & Rehabilitation Department, Azienda USL-IRCCS di Reggio Emilia, Italy.
  5. Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  6. Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  7. Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

CER17542
2024 Vol.42, N°2
PI 0462, PF 0463
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 38372729 [PubMed]

Received: 06/02/2024
Accepted : 13/02/2024
In Press: 19/02/2024
Published: 14/03/2024

DOI: https://doi.org/10.55563/clinexprheumatol/7x5o3q

Rheumatology Article